Microbix Biosystems Inc. (MBXBF)
OTCMKTS
· Delayed Price · Currency is USD
0.2500
-0.0100 (-3.85%)
May 15, 2025, 1:11 PM EDT
Microbix Biosystems Balance Sheet
Financials in millions CAD. Fiscal year is October - September.
Millions CAD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2015 - 2019 |
| Cash & Equivalents | 14.54 | 12.96 | 11.61 | 13.49 | 9.99 | 0.09 | Upgrade
|
| Cash & Short-Term Investments | 14.54 | 12.96 | 11.61 | 13.49 | 9.99 | 0.09 | Upgrade
|
| Cash Growth | 12.94% | 11.69% | -13.95% | 35.07% | 10677.25% | -3.04% | Upgrade
|
| Accounts Receivable | 2.49 | 4.16 | 4.12 | 3.06 | 4.18 | 1.88 | Upgrade
|
| Other Receivables | 0.03 | 0.03 | 0.06 | 0.03 | 0.03 | 0.01 | Upgrade
|
| Receivables | 2.51 | 4.19 | 4.18 | 3.09 | 4.21 | 1.89 | Upgrade
|
| Inventory | 8.28 | 6.46 | 5.75 | 5.28 | 4.41 | 4.29 | Upgrade
|
| Prepaid Expenses | 0.62 | 0.64 | 0.77 | 0.55 | 0.5 | 0.22 | Upgrade
|
| Total Current Assets | 25.95 | 24.26 | 22.3 | 22.41 | 19.09 | 6.49 | Upgrade
|
| Property, Plant & Equipment | 9.45 | 9.62 | 8.93 | 8.91 | 8.08 | 7.36 | Upgrade
|
| Other Intangible Assets | 3.97 | 4.22 | 4.42 | 1.5 | 1.65 | 1.74 | Upgrade
|
| Other Long-Term Assets | - | - | - | 0.33 | - | - | Upgrade
|
| Total Assets | 39.37 | 38.1 | 35.65 | 33.15 | 28.83 | 15.6 | Upgrade
|
| Accounts Payable | 1.94 | 2.66 | 2.08 | 1.83 | 1.79 | 1.49 | Upgrade
|
| Current Portion of Long-Term Debt | 0.01 | 0.11 | 0.11 | 0.11 | 2.45 | 1.13 | Upgrade
|
| Current Portion of Leases | 0.09 | 0.13 | 0.16 | 0.16 | 0.21 | 0.16 | Upgrade
|
| Current Unearned Revenue | 0.73 | 0.49 | 2 | 0.55 | 0.74 | 1.32 | Upgrade
|
| Other Current Liabilities | - | - | -0 | - | - | - | Upgrade
|
| Total Current Liabilities | 2.77 | 3.39 | 4.35 | 2.65 | 5.19 | 4.09 | Upgrade
|
| Long-Term Debt | 4.72 | 5.59 | 5.68 | 4.71 | 4.09 | 4.51 | Upgrade
|
| Long-Term Leases | 0.54 | 0.57 | 0.7 | 0.85 | 0.99 | 0.38 | Upgrade
|
| Long-Term Unearned Revenue | - | 0.25 | 0.3 | - | - | - | Upgrade
|
| Total Liabilities | 8.31 | 9.8 | 11.03 | 8.21 | 10.27 | 8.98 | Upgrade
|
| Common Stock | 50.99 | 48.68 | 49.04 | 49.92 | 43.61 | 35.36 | Upgrade
|
| Additional Paid-In Capital | 10.32 | 10.73 | 10.22 | 9.62 | 10.7 | 10.25 | Upgrade
|
| Retained Earnings | -32.51 | -33.39 | -36.91 | -36.87 | -38.66 | -41.89 | Upgrade
|
| Comprehensive Income & Other | 2.27 | 2.27 | 2.27 | 2.27 | 2.9 | 2.9 | Upgrade
|
| Shareholders' Equity | 31.06 | 28.3 | 24.62 | 24.94 | 18.56 | 6.62 | Upgrade
|
| Total Liabilities & Equity | 39.37 | 38.1 | 35.65 | 33.15 | 28.83 | 15.6 | Upgrade
|
| Total Debt | 5.35 | 6.4 | 6.65 | 5.82 | 7.74 | 6.17 | Upgrade
|
| Net Cash (Debt) | 9.19 | 6.57 | 4.96 | 7.66 | 2.25 | -6.08 | Upgrade
|
| Net Cash Growth | 49.20% | 32.41% | -35.30% | 240.46% | - | - | Upgrade
|
| Net Cash Per Share | 0.06 | 0.05 | 0.04 | 0.05 | 0.02 | -0.06 | Upgrade
|
| Filing Date Shares Outstanding | 157.63 | 135.54 | 136.85 | 138.99 | 126.38 | 108.77 | Upgrade
|
| Total Common Shares Outstanding | 157.63 | 135.54 | 136.85 | 138.99 | 126.38 | 108.77 | Upgrade
|
| Working Capital | 23.17 | 20.87 | 17.95 | 19.76 | 13.9 | 2.4 | Upgrade
|
| Book Value Per Share | 0.20 | 0.21 | 0.18 | 0.18 | 0.15 | 0.06 | Upgrade
|
| Tangible Book Value | 27.09 | 24.08 | 20.2 | 23.44 | 16.9 | 4.88 | Upgrade
|
| Tangible Book Value Per Share | 0.17 | 0.18 | 0.15 | 0.17 | 0.13 | 0.04 | Upgrade
|
| Land | - | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | Upgrade
|
| Buildings | - | 6.62 | 6.27 | 6.2 | 5.28 | 5.17 | Upgrade
|
| Machinery | - | 10.1 | 8.62 | 7.67 | 6.9 | 6.45 | Upgrade
|
Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.